Jacobs Levy Equity Management’s Colgate-Palmolive CL Stock Holding History

Jacobs Levy Equity Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Sell	22,252 -102,056	-82%	-$8.93M	0.01%	589
2026 Q1	$10.6M	Buy	124,308 +56,157	+82%	+$5.01M	0.04%	297
2025 Q4	$5.39M	Sell	68,151 -39,253	-37%	-$3.08M	0.02%	391
2025 Q3	$8.59M	Buy	107,404 +73,611	+218%	+$6.28M	0.03%	326
2025 Q2	$3.07M	Sell	33,793 -174,563	-84%	-$15.9M	0.01%	548
2025 Q1	$19.5M	Sell	208,356 -395,697	-66%	-$35.4M	0.08%	227
2024 Q4	$54.9M	Sell	604,053 -173,801	-22%	-$16.6M	0.19%	124
2024 Q3	$80.7M	Buy	777,854 +697,168	+864%	+$71.1M	0.31%	83
2024 Q2	$7.83M	Buy	+80,686	New	+$7.44M	0.03%	369
2020 Q1	–	Sell	-19,950	Closed	-$1.37M	–	1013
2019 Q4	$1.37M	Sell	19,950 -28,580	-59%	-$1.95M	0.01%	621
2019 Q3	$3.57M	Sell	48,530 -28,570	-37%	-$2.07M	0.04%	395
2019 Q2	$5.53M	Sell	77,100 -4,810	-6%	-$341K	0.08%	323
2019 Q1	$5.61M	Buy	81,910 +26,600	+48%	+$1.72M	0.08%	308
2018 Q4	$3.29M	Sell	55,310 -50,010	-47%	-$3.13M	0.06%	348
2018 Q3	$7.05M	Sell	105,320 -117,960	-53%	-$7.86M	0.1%	236
2018 Q2	$14.5M	Sell	223,280 -32,770	-13%	-$2.14M	0.23%	130
2018 Q1	$18.4M	Buy	256,050 +230,910	+918%	+$16.6M	0.31%	106
2017 Q4	$1.9M	Buy	25,140 +14,580	+138%	+$1.06M	0.03%	472
2017 Q3	$769K	Buy	+10,560	New	+$761K	0.01%	633
2017 Q1	–	Sell	-7,770	Closed	-$508K	–	925
2016 Q4	$508K	Buy	7,770 +1,470	+23%	+$101K	0.01%	678
2016 Q3	$467K	Sell	6,300 -830	-12%	-$61.4K	0.01%	726
2016 Q2	$522K	Buy	+7,130	New	+$508K	0.01%	740
2014 Q3	–	Sell	-24,750	Closed	-$1.69M	–	833
2014 Q2	$1.69M	Sell	24,750 -260	-1%	-$17.4K	0.03%	427
2014 Q1	$1.62M	Sell	25,010 -248,040	-91%	-$15.6M	0.03%	437
2013 Q4	$17.8M	Sell	273,050 -84	-0%	-$5.38K	0.27%	117
2013 Q3	$16.2M	Sell	273,134 -501,084	-65%	-$29.7M	0.27%	121
2013 Q2	$44.4M	Buy	+774,218	New	+$46M	0.78%	18

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jacobs Levy Equity Management's CL Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Colgate-Palmolive (CL) stake by 82% in Q2 2026, selling an estimated $8.93M and leaving 22,252 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #589.

Jacobs Levy Equity Management first reported a position in CL in Q2 2013 and has held it in 27 quarters since. The position peaked at $80.7M in Q3 2024. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Jacobs Levy Equity Management held 22,252 shares of Colgate-Palmolive worth $2.04M as of Q2 2026.
Jacobs Levy Equity Management sold 102,056 Colgate-Palmolive shares in Q2 2026, an estimated $8.93M.
Colgate-Palmolive made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #589 holding.
Jacobs Levy Equity Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 27 quarters since.
Jacobs Levy Equity Management's Colgate-Palmolive position peaked at $80.7M in Q3 2024.
2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.